Linking variability in brain chemistry and circuit function through multimodal human neuroimaging.

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Imaging

Background:

• Understanding individual differences in behavior is key to identifying psychopathology risk.
• Neuroreceptor positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) measure brain chemistry and function, respectively.
• These neuroimaging modalities are often used separately, limiting comprehensive insights.

Purpose of the Study:

• To review the implementation of multimodal neuroimaging strategies.
• To demonstrate how integrating PET and fMRI can illuminate molecular mechanisms of brain function.
• To explore the application of multimodal PET-fMRI in understanding behavioral differences and psychopathology risk.

Main Methods:

• Reviewing existing evidence on serotonin and dopamine systems.
• Utilizing examples of threat- and reward-related brain function.
• Discussing the integration of PET-fMRI with imaging genetics, pharmacological challenges, and gene-environment interaction models.

Main Results:

• Multimodal neuroimaging offers unique insights into molecular mechanisms of brain function.
• Integration of PET and fMRI can map biological pathways mediating behavior.
• This approach can reveal links between neurobiology, behavior, and psychopathology risk.

Conclusions:

• Multimodal PET-fMRI is a powerful strategy for studying individual differences in behavior.
• This integrated approach can significantly advance our understanding of psychopathology.
• It holds promise for informing the development of novel therapeutic targets.